Dr John Weight Loss Pharmacy - Products

Mozobil® is a prescription injectable medication that contains plerixafor, a hematopoietic stem cell mobilizer. It is used in combination with granulocyte-colony stimulating factor (G-CSF) to help collect hematopoietic stem cells (HSCs) from the bloodstream for use in autologous stem cell transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma. Plerixafor works by blocking the CXCR4 receptor, which causes stem cells to move from the bone marrow into the bloodstream, making them easier to collect through a process called apheresis. Used with G-CSF to enhance stem cell mobilization Administered subcutaneously (under the skin) Typically given 6–11 hours before apheresis Increases the likelihood of successful stem cell collection for transplant Mozobil is not used alone for stem cell mobilization and is prescribed under the supervision of a healthcare professional experienced in stem cell transplantation procedures.

Saxenda® is a once-daily injectable prescription medication that contains liraglutide, a GLP-1 receptor agonist approved for weight management in adults and adolescents (aged 12–17) with obesity, or in adults who are overweight with at least one weight-related health condition (such as type 2 diabetes, high blood pressure, or high cholesterol). Saxenda works by mimicking the GLP-1 hormone that targets areas of the brain involved in appetite regulation. It helps to: Reduce hunger and control cravings Slow digestion to increase satiety Lower calorie intake Support gradual and sustained weight loss Saxenda is titrated up to a daily maintenance dose of 3.0 mg and is administered using a prefilled injection pen. It is intended to be used in combination with a reduced-calorie diet and increased physical activity as part of a long-term weight management plan.

Wegovy is a once-weekly injectable prescription medication containing semaglutide, a GLP-1 receptor agonist specifically approved by the FDA for chronic weight management in adults and adolescents with obesity or overweight and at least one weight-related health condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol). Wegovy works by mimicking a natural hormone (GLP-1) that regulates appetite and food intake. It: Reduces hunger and increases satiety Slows gastric emptying Helps decrease calorie intake Promotes significant and sustained weight loss It is available in prefilled pens with the following weekly doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg (maximum maintenance dose). Wegovy should be used alongside a reduced-calorie diet and increased physical activity and is not intended for short-term use.

Ozempic is a once-weekly injectable prescription medication that contains semaglutide, a GLP-1 receptor agonist designed to help adults with type 2 diabetes manage their blood sugar levels. It also supports weight loss by reducing appetite, slowing digestion, and improving satiety. Although Ozempic is primarily approved for diabetes treatment, it is widely used off-label for weight loss, due to its strong effect on reducing body weight. A higher-dose version of semaglutide formulated specifically for weight management is available under the brand name Wegovy®. Ozempic is delivered through a user-friendly, prefilled injection pen in once-weekly doses, commonly available in 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths.

Mounjaro® is a once-weekly injectable prescription medication containing tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist. It is approved for the treatment of type 2 diabetes and is widely recognized for its powerful weight loss effects, even though it is not officially labeled for that purpose. By mimicking two natural hormones—GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)—Mounjaro helps: Improve blood sugar control Reduce appetite and cravings Slow gastric emptying Promote significant and sustained weight loss Mounjaro is available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, and is administered via a simple, prefilled pen once a week. It is typically prescribed as part of a comprehensive treatment plan that includes a healthy diet, exercise, and lifestyle changes. A weight loss–specific version of tirzepatide is marketed under the brand Zepbound.